Learn
Explore our list of resources
Depending on your rare disease journey, Global Genes provides you with the resource and community to enhance your learning.
Featured
Gene-Based Diagnosis 101: How to Successfully Navigate the Diagnostic Journey
As scientific innovation in genomic medicine continues to provide more hope for therapeutic options, there is a […]
Read moreA Case for Whole Genome Sequencing
The ability to diagnose rare genetic diseases through the use of genetic sequencing has improved to a […]
Read moreAdvances in Rare Immunological Diseases
Recent advances in rare immunological diseases have raised the exciting potential of cures for some disorders. Hear […]
Read moreDevelopmental Delays After Factor V Leiden Pregnancy
by Tiffany Burnette I was diagnosed with Factor V Leiden when I was pregnant with Sammy. While […]
Read morePatient Stories
Living and Advocating Through a Complex Medical Journey: Erythromelalgia, Visual Snow Syndrome, and Autoimmune Dysregulation
Hello, my name is Sierra Domb. Since childhood, I have experienced Erythromelalgia (EM) and Autoimmune Dysregulation (AD). […]
Read moreLiving with Brugada Syndrome
Brugada is insidious, especially for someone my age. It tends to “hide” in the ECG. Many times, it looks normal… but it isn’t. And with the myocarditis I had at the same time, it was even harder to get a correct diagnosis. The doctors didn’t know whether the findings were due to Brugada or to myocarditis. After my hospitalization, and after I suffered a fainting episode, it was finally decided that I should be implanted with a defibrillator (ICD). When it happened, I felt like life was given back to me.
Read moreHe Is Three. His Voice Isn’t Lost —It’s Waiting to Be Heard.
By the time a genetic diagnosis of a rare mutation in the PPP3CA gene finally arrived, critical months — even years — had slipped away. Milestones were missed while we waited for answers. Early concerns were minimized, and our pleas for help were too often brushed aside until delays became severe. That delay is not just a bureaucratic failure; it is lost opportunity — lost time for therapies that could have helped him build strength, communication, and independence.
Read moreThe Beginning of Our Lowe Syndrome Journey
By Caroline Tsai The sun blazes overhead without a cloud in sight. Only a high of 90 […]
Read moreInvincible Never Invisible: A Decade of InvisiYouth
I was competitive tennis player as a teen and was unfortunately injured in training, which resulted in dealing with an injury and neurovascular condition that changed the trajectory of my life. I was thrust into the world of living with a chronic illness, years of trying to find proper diagnoses and treatments, all while balancing life as a teen/young adult. During this entire young adult experience, my doctors would tell me “wait” till they could fix my health to live my life fully… I created InvisiYouth out of my love of philanthropy, and my newfound passion to giving a voice for the young adult population living with all chronic illnesses and disabilities for the non-medical aspects of their lives with health struggles.
Read moreBeauty in Being Rare
Classical HCU is a condition in which my liver has a defective enzyme that is supposed to break down methionine. Instead, it builds up and turns into homocysteine, which is extremely toxic to your body. These elevated levels can result in blood clots, strokes, and other life-threatening complications. I follow an extremely restrictive low-protein diet—only about 10 grams of whole protein per day—alongside a methionine-free formula, the medication called betaine, and a cocktail of vitamins and supplements.
Read moreLatest News
Publication Announcement — RARE-X: Advancing Rare Disease Research Through Patient-Driven Data
Global Genes is excited to announce “RARE-X: A patient-driven approach for collecting symptom and patient-reported outcome data […]
Read moreAccelerating Rare Disease Research Through Collaboration: Global Genes and Notre Dame Launch the Research Acceleration Program
Global Genes and University of Notre Dame have partnered to launch the Research Acceleration Program, a collaborative […]
Read moreRARE Advocacy Exchange Session 8, Knowing Your Rare Rights
This session recording is from Oct. 16, 2025 Rare Advocacy Exchange Session 8: Knowing the Rights for […]
Read moreGlobal Genes Guide to Cooperating Among Patient Advocacy Organizations
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Starting a Nonprofit Patient Advocacy Organization
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreRARE Advocacy Exchange Session 7, Getting a Precise Genetic Diagnosis
This session recording is from Sept. 18, 2025 Rare Advocacy Exchange Session 7: Getting A Precise Diagnosis […]
Read moreIndustry News
FDA Grants Immusoft RPPD for MPSII Cell Therapy
Rare Daily Staff The U.S. Food and Drug Administration granted Immusoft Rare Pediatric Disease designation to ISP-002, […]
Read moreSarepta Reports Three-Year Topline Data from Phase 3 DMD Study
Rare Daily Staff Sarepta Therapeutics said data from a phase 3 study of its gene therapy Elevidys […]
Read moreOcugen Closes $22.5 Million Offering
Rare Daily Staff Ocugen, which is developing gene therapies for blinding diseases, said it raised $22.5 million […]
Read moreMendra Launches with $82 Million to Focus on Unmet Needs in Rare Disease
Rare Daily Staff Mendra, a biopharmaceutical company seeking to advance rare disease therapies utilizing artificial intelligence, announced […]
Read moreFinding a Ready Treatment for a Newly Discovered, Ultra-Rare Disease
When a toddler with a neurodevelopmental delay, poor muscle tone, and no hair came to Caleb Bupp’s […]
Read moreIntraBio’s A-T Therapy Meets Phase 3 Endpoints, Will Seek FDA Approval
IntraBio reported topline results from its pivotal phase 3 clinical trial of its experimental therapy levacetylleucine for […]
Read moreCharles River Enters Manufacturing Collaboration with Gazi University
Rare Daily Staff Charles River Laboratories International has partnered with Ankara-based Gazi University Faculty of Medicine to […]
Read moreOne Rare Mother’s Quest to Rewrite Her Son’s Future with a Gene Therapy
Amber Freed transformed the shock of her son’s diagnosis with an ultra-rare neurodevelopmental disorder into a determined […]
Read moren-Lorem Enters Collaboration with EspeRare to Expand Access to Individualized ASOs for Rare Genetic Diseases
Rare Daily Staff The n-Lorem Foundation and the Geneva-based EspeRare Foundation said they have entered a strategic […]
Read moreGenetic Counseling
Global Genes Guide to Genetic Diagnosis
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes 2025 Quick Guide Series
We are excited to announce the launch of a new series of Quick Guides for the […]
Read moreAngelina Spreading Light, Love, and Inspiration on CASK Gene Awareness Day
To recognize CASK Gene Awareness Day on July 15, Global Genes reached out to Giovi Moschoudis, mother […]
Read moreTeam Wally Inspires During Fragile X Awareness Month
To recognize Fragile X Awareness Month in July, Global Genes reached out to National Fragile X Foundation, […]
Read moreFrom First Symptoms to Advocate for Transverse Myelitis
To recognize Transverse Myelitis Awareness Month in June, Global Genes reached out to The MOG Project, a […]
Read moreMoving from Awareness to Action after Sickle Cell Disease Diagnosis
Karen L. Proudford, Ph.D. is the President of Williams E. Proudford Sickle Cell Fund, Inc., and daughter […]
Read moreResearch Readiness
A Gene Editing Approach to Work Across Multiple Diseases
Rare Daily Staff Researchers at the Broad Institute have developed a new genome-editing strategy that could potentially […]
Read moreNIH Makes $14.4 Million Award to Launch Initiative to Bring WGS to Newborn Screening
NIH Makes $14.4 Million Award to Launch Initiative to Bring WGS to Newborn Screening Rare Daily Staff […]
Read moreNIH awards Baylor $15.6 million to fund two rare diseases consortia
NIH awards Baylor $15.6 Million to Fund Two Rare Diseases Consortia Rare Daily Staff The National Institutes […]
Read moreNIH launches $50 Million Autism Data Science Initiative
Rare Daily Staff The National Institutes of Health has launched the Autism Data Science Initiative, a $50 […]
Read moreNIH Awards $8.6 Million Grant to Study Neurodevelopmental Conditions
Rare Daily Staff The National Institutes of Health awarded Mustafa Sahin, neurologist-in-chief and chair of the Department […]
Read moreNCATS Launches Challenge to Spotlight Rare Disease Research
Rare Daily Staff The National Center for Advancing Translational Sciences announced the launch of its 2025-2026 Rare […]
Read moreMental Health & Wellness
RARE Advocacy Exchange Session 6 : Grieving a RARE Diagnosis
Rare disease grief differs from the grief we commonly associate with losing a loved one to death. […]
Read moreA Student’s Perspective: Lessons from the 2025 RARE Drug Development Symposium
During my first week as a Harvard College junior, I was delighted to be given the opportunity […]
Read moreGlobal Genes Guide to Securing a State Proclamation for Rare Disease Awareness
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Your Rare Rights
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Fundraising
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Comprehensive Fundraising Strategic Documents
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreRARE Advocacy Exchange Session 5 : Interacting with FDA: PFDD and Listening Sessions
If your rare disease is likely to have a clinical trial for a drug or treatment come […]
Read moreA PAG Leader Guide to Presenting the Patient Experience at Your EL-PFDD Session with the FDA.
A Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreLove, Advocacy, and Belonging: Reflections from a Rare Disease Ally
By Nicole Boice, Chief Mission Officer, Global Genes As Chief Mission Officer at Global Genes—and as the […]
Read moreRARE Daily
FDA Approves Sentynl’s Menkes Disease Therapy
Rare Daily Staff The U.S. Food and Drug Administration approved Sentynl Therapeutics’ Zycubo, the first treatment in […]
Read moreDoudna’s Aurora Launches with $16 Million to Industrialize Personalized Genetic Therapies
Rare Daily Staff Aurora Therapeutics, a company seeking to transform personalized gene editing from a one-patient breakthrough […]
Read moreFinancial News Channel Launches CNBC Cures to Raise Rare Disease Awareness
Rare Daily Staff The financial news cable channel CNBC announced the launch of CNBC Cures, an effort to […]
Read moreTransforming TSC Epilepsy with a Precision Therapy
Tuberous sclerosis complex is a rare genetic condition caused by changes in the TSC1 or TSC2 gene […]
Read moreZenas Reports Positive Results from Phase 3 Study in IgG4-RD, But Stock Sinks
Rare Daily Staff Zenas BioPharma reported positive results from its Phase 3 trial of obexelimab, an experimental […]
Read moreArgenx Announces Leadership Transition
Rare Daily Staff Argenx, a drug developer focused on rare autoimmune diseases, said Karen Massey, current chief […]
Read moreSearch the RARE List
For more resources, disease-specific information, and news, search our RARE List- an extensive list of rare diseases and rare conditions.
Search Our Full RARE List